Currency in BRL
| Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 0.78 | 0.88 | 2.08 | 2.75 |
| Low estimate | 0.39 | 0.37 | 1.47 | 2.11 |
| High estimate | 1.18 | 1.4 | 2.69 | 3.39 |
| Year ago EPS | 0.35 | 0.2 | 0.58 | 2.08 |
| Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 2 | 2 | 4 | 4 |
| Avg. Estimate | 7.97B | 7.82B | 32.84B | 37.11B |
| Low estimate | 7.91B | 7.35B | 30.99B | 33.45B |
| High estimate | 8.04B | 8.28B | 33.86B | 39.11B |
| Year ago sales | 6.35B | N/A | 28.15B | 32.84B |
| Sales growth (year/est) | 25.60% | N/A | 16.70% | 13.00% |
| Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
|---|
| Est. EPS | 0.59 | 0.84 | 2.15 | -0.34 |
| Actual EPS | 0.35 | 0.2 | 0.56 | -0.09 |
| Difference | -0.24 | -0.64 | -1.59 | 0.25 |
| Surprise % | -40.70% | -76.20% | -74.00% | 73.50% |
| EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0.78 | 0.88 | 2.08 | 2.75 |
| 7 days ago | 0.79 | 0.88 | 2.07 | 2.74 |
| 30 days ago | 0.38 | 0.36 | 2 | 2.64 |
| 60 days ago | 0.39 | 0.37 | 2.71 | 4.11 |
| 90 days ago | 0 | 0 | 3.02 | 4.35 |
| EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | 1 | 1 |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | EMBR3.SA | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | 122.90% | N/A | N/A | N/A |
| Next qtr. | 340.00% | N/A | N/A | N/A |
| Current year | 258.60% | N/A | N/A | N/A |
| Next year | 32.20% | N/A | N/A | N/A |
| Next 5 years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 years (per annum) | -2.59% | N/A | N/A | N/A |
